Esperion Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 149386000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/08f0b1a0-534f-4903-aa35-662eee9e5a40
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-20-057549Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/cash-and-equivalents/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/08f0b1a0-534f-4903-aa35-662eee9e5a40
History
- no predecessors — first report